Edesa Biotech, Inc. company info

CIK 1540159
IRS Number 000000000
State of incorporation A1
Business address 100 SPY COURT
None
MARKHAM
A6
L3R 5H6
Mail address 100 SPY COURT
None
MARKHAM
A6
L3R 5H6

Short summary

Edesa Biotech, Inc. is a Ontario, Canada company, with head office located at 100 Spy Court Markham, Ontario, Canada L3R 5H6. In 2018 the company owned a total of 7.23 million USD worth of assets, including 7.12 million USD worth of current assets and 1.01 million USD worth of non-current assets. 2013 was the year when the company amassed the most assets.

Edesa Biotech, Inc. Income Statement

Name [in Millions USD]20112012201320142015201620172018Trends
Cost of Goods and Services Sold 0.060.470.580.820.250.13
Research and development 2.632.022.461.031.731.972.09
Operating Expenses 6.834.396.095.106.185.455.29
Operating Income (Loss) -5.72-4.34-4.91-5.22-5.08
Income Tax Expense (Benefit) 0.000.000.030.040.010.000.00
Net income -5.53-14.50-8.44-2.84-5.03-5.03-5.04

Edesa Biotech, Inc. Balance Sheet

Name [in Millions USD]20112012201320142015201620172018Trends
Cash and cash equivalents 4.151.0014.4410.164.793.655.826.36
Accounts Receivable, Net, Current 0.020.06
Inventories 0.190.570.140.240.08
Property, Plant and Equipment, Gross 0.640.960.05
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 0.390.640.750.921.100.03
Other Assets, Noncurrent 0.02
Total assets 16.0711.218.509.0212.807.23
Current assets 8.1310.737.738.1211.637.12
Non-current assets 0.370.490.770.901.171.01
Total current liabilities 3.871.780.840.430.411.02
Total liabilities 10.711.782.38
Common Stock, Value, Issued 13.1837.9441.3448.3556.6512.01
Retained Earnings (Accumulated Deficit) -25.18-33.80-39.02-44.17-49.30-5.78
Accumulated Other Comprehensive Income (Loss), Net of Tax -0.33

Edesa Biotech, Inc. Cash Flow

Name [in Millions USD]20112012201320142015201620172018Trends
Net income -5.53-14.50-8.44-2.84-5.03-5.03-5.04
Depreciation and amortization 0.080.100.130.160.150.180.19
Depreciation 0.180.19
Amortization of Intangible Assets 0.030.030.03
Depreciation and amortization 0.110.120.160.160.150.18
Accounts receivable -0.030.19-0.120.11-0.07-0.080.04
Inventories 00.52-0.31-0.180.16
Deferred revenue 0.13-0.130.020.09-0.17
Net Cash Provided by (Used in) Operating Activities -4.41-4.51-4.70-4.62
Payments to Acquire Property, Plant, and Equipment 0.080.010.280.270.400.300.38
Net Cash Provided by (Used in) Investing Activities 0.120.561.69-4.47
Net Cash Provided by (Used in) Investing Activities, Continuing Operations -0.08-0.01-0.740.120.56
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 000
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 000
Proceeds from Issuance of Common Stock 8.156.6106.2804.52
Net Cash Provided by (Used in) Financing Activities 0.117.3108.77
Cash and Cash Equivalents, Period Increase (Decrease) -3.156.860.56-4.813.46-2.85-0.35